Description

• Cagrilintide is a long-acting analog of the hormone amylin, which is involved in promoting satiety and slowing gastric emptying. Research has explored its potential role in appetite regulation and body weight management.
• Semaglutide is a GLP-1 receptor agonist that has been studied for its effects on glucose metabolism, insulin secretion, appetite control, and energy intake.

When combined, researchers investigate whether these compounds may have complementary effects related to:

• Appetite regulation
• Satiety signaling
• Metabolic function
• Energy balance
• Body weight management research